カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のヒト用ワクチン接種市場予測2023-2029：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他

【英語タイトル】Human Vaccination Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8782）・商品コード：MMG23LY8782
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のヒト用ワクチン接種市場規模と予測を収録しています。・世界のヒト用ワクチン接種市場：売上、2018年-2023年、2024年-2029年
・世界のヒト用ワクチン接種市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト用ワクチン接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「不活化ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒト用ワクチン接種のグローバル主要企業は、GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 KM Biologics、 LG Life Sciences、 Serum Institute、 Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヒト用ワクチン接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒト用ワクチン接種市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン接種市場：タイプ別市場シェア、2022年
・不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他

世界のヒト用ワクチン接種市場：用途別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン接種市場：用途別市場シェア、2022年
・政府機関、民間企業、その他

世界のヒト用ワクチン接種市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン接種市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒト用ワクチン接種のグローバル売上、2018年-2023年
・主要企業におけるヒト用ワクチン接種のグローバル売上シェア、2022年
・主要企業におけるヒト用ワクチン接種のグローバル販売量、2018年-2023年
・主要企業におけるヒト用ワクチン接種のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 KM Biologics、 LG Life Sciences、 Serum Institute、 Pfizer

*************************************************************

・調査・分析レポートの概要
ヒト用ワクチン接種市場の定義
市場セグメント
世界のヒト用ワクチン接種市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト用ワクチン接種市場規模
世界のヒト用ワクチン接種市場規模：2022年 VS 2029年
世界のヒト用ワクチン接種市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト用ワクチン接種の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト用ワクチン接種製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他
ヒト用ワクチン接種のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：政府機関、民間企業、その他
ヒト用ワクチン接種の用途別グローバル売上・予測

・地域別市場分析
地域別ヒト用ワクチン接種市場規模 2022年と2029年
地域別ヒト用ワクチン接種売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Merck、 Sanofi、 Sinovac、 Zhejiang Pukang、 Changchun Institute of Biological、 KM Biologics、 IMBCAMS、 Convac、 NCPC、 Bio Kangtai、 Dynavax、 Hissen、 KM Biologics、 LG Life Sciences、 Serum Institute、 Pfizer
...

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or “wild” pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
This report aims to provide a comprehensive presentation of the global market for Human Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccination. This report contains market size and forecasts of Human Vaccination in global, including the following market information:
Global Human Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Human Vaccination companies in 2022 (%)
The global Human Vaccination market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Inactivated Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Vaccination include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Vaccination Market Segment Percentages, by Type, 2022 (%)
Inactivated Vaccine
Live-attenuated Vaccine
mRNA Vaccine
Conjugate Vaccine
Other
Global Human Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Vaccination Market Segment Percentages, by Application, 2022 (%)
Government Institution
Private Sector
Other
Global Human Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Vaccination revenues share in global market, 2022 (%)
Key companies Human Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Human Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Vaccination, market overview.
Chapter 2: Global Human Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Human Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Vaccination Overall Market Size
2.1 Global Human Vaccination Market Size: 2022 VS 2029
2.2 Global Human Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Human Vaccination Players in Global Market
3.2 Top Global Human Vaccination Companies Ranked by Revenue
3.3 Global Human Vaccination Revenue by Companies
3.4 Global Human Vaccination Sales by Companies
3.5 Global Human Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Vaccination Market Size Markets, 2022 & 2029
4.1.2 Inactivated Vaccine
4.1.3 Live-attenuated Vaccine
4.1.4 mRNA Vaccine
4.1.5 Conjugate Vaccine
4.1.6 Other
4.2 By Type – Global Human Vaccination Revenue & Forecasts
4.2.1 By Type – Global Human Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Human Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Human Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Human Vaccination Sales & Forecasts
4.3.1 By Type – Global Human Vaccination Sales, 2018-2023
4.3.2 By Type – Global Human Vaccination Sales, 2024-2029
4.3.3 By Type – Global Human Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Human Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Vaccination Market Size, 2022 & 2029
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application – Global Human Vaccination Revenue & Forecasts
5.2.1 By Application – Global Human Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Human Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Human Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Human Vaccination Sales & Forecasts
5.3.1 By Application – Global Human Vaccination Sales, 2018-2023
5.3.2 By Application – Global Human Vaccination Sales, 2024-2029
5.3.3 By Application – Global Human Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Human Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Human Vaccination Revenue & Forecasts
6.2.1 By Region – Global Human Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Human Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Human Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Human Vaccination Sales & Forecasts
6.3.1 By Region – Global Human Vaccination Sales, 2018-2023
6.3.2 By Region – Global Human Vaccination Sales, 2024-2029
6.3.3 By Region – Global Human Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Human Vaccination Sales, 2018-2029
6.4.3 US Human Vaccination Market Size, 2018-2029
6.4.4 Canada Human Vaccination Market Size, 2018-2029
6.4.5 Mexico Human Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Human Vaccination Sales, 2018-2029
6.5.3 Germany Human Vaccination Market Size, 2018-2029
6.5.4 France Human Vaccination Market Size, 2018-2029
6.5.5 U.K. Human Vaccination Market Size, 2018-2029
6.5.6 Italy Human Vaccination Market Size, 2018-2029
6.5.7 Russia Human Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Human Vaccination Market Size, 2018-2029
6.5.9 Benelux Human Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Human Vaccination Sales, 2018-2029
6.6.3 China Human Vaccination Market Size, 2018-2029
6.6.4 Japan Human Vaccination Market Size, 2018-2029
6.6.5 South Korea Human Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Human Vaccination Market Size, 2018-2029
6.6.7 India Human Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Human Vaccination Sales, 2018-2029
6.7.3 Brazil Human Vaccination Market Size, 2018-2029
6.7.4 Argentina Human Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Vaccination Sales, 2018-2029
6.8.3 Turkey Human Vaccination Market Size, 2018-2029
6.8.4 Israel Human Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Human Vaccination Market Size, 2018-2029
6.8.6 UAE Human Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Human Vaccination Major Product Offerings
7.1.4 GSK Human Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Human Vaccination Major Product Offerings
7.2.4 Merck Human Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Vaccination Major Product Offerings
7.3.4 Sanofi Human Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Sinovac
7.4.1 Sinovac Company Summary
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Human Vaccination Major Product Offerings
7.4.4 Sinovac Human Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 Sinovac Key News & Latest Developments
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Company Summary
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Human Vaccination Major Product Offerings
7.5.4 Zhejiang Pukang Human Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 Zhejiang Pukang Key News & Latest Developments
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Company Summary
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Human Vaccination Major Product Offerings
7.6.4 Changchun Institute of Biological Human Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 Changchun Institute of Biological Key News & Latest Developments
7.7 KM Biologics
7.7.1 KM Biologics Company Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Human Vaccination Major Product Offerings
7.7.4 KM Biologics Human Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 KM Biologics Key News & Latest Developments
7.8 IMBCAMS
7.8.1 IMBCAMS Company Summary
7.8.2 IMBCAMS Business Overview
7.8.3 IMBCAMS Human Vaccination Major Product Offerings
7.8.4 IMBCAMS Human Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 IMBCAMS Key News & Latest Developments
7.9 Convac
7.9.1 Convac Company Summary
7.9.2 Convac Business Overview
7.9.3 Convac Human Vaccination Major Product Offerings
7.9.4 Convac Human Vaccination Sales and Revenue in Global (2018-2023)
7.9.5 Convac Key News & Latest Developments
7.10 NCPC
7.10.1 NCPC Company Summary
7.10.2 NCPC Business Overview
7.10.3 NCPC Human Vaccination Major Product Offerings
7.10.4 NCPC Human Vaccination Sales and Revenue in Global (2018-2023)
7.10.5 NCPC Key News & Latest Developments
7.11 Bio Kangtai
7.11.1 Bio Kangtai Company Summary
7.11.2 Bio Kangtai Human Vaccination Business Overview
7.11.3 Bio Kangtai Human Vaccination Major Product Offerings
7.11.4 Bio Kangtai Human Vaccination Sales and Revenue in Global (2018-2023)
7.11.5 Bio Kangtai Key News & Latest Developments
7.12 Dynavax
7.12.1 Dynavax Company Summary
7.12.2 Dynavax Human Vaccination Business Overview
7.12.3 Dynavax Human Vaccination Major Product Offerings
7.12.4 Dynavax Human Vaccination Sales and Revenue in Global (2018-2023)
7.12.5 Dynavax Key News & Latest Developments
7.13 Hissen
7.13.1 Hissen Company Summary
7.13.2 Hissen Human Vaccination Business Overview
7.13.3 Hissen Human Vaccination Major Product Offerings
7.13.4 Hissen Human Vaccination Sales and Revenue in Global (2018-2023)
7.13.5 Hissen Key News & Latest Developments
7.14 KM Biologics
7.14.1 KM Biologics Company Summary
7.14.2 KM Biologics Business Overview
7.14.3 KM Biologics Human Vaccination Major Product Offerings
7.14.4 KM Biologics Human Vaccination Sales and Revenue in Global (2018-2023)
7.14.5 KM Biologics Key News & Latest Developments
7.15 LG Life Sciences
7.15.1 LG Life Sciences Company Summary
7.15.2 LG Life Sciences Business Overview
7.15.3 LG Life Sciences Human Vaccination Major Product Offerings
7.15.4 LG Life Sciences Human Vaccination Sales and Revenue in Global (2018-2023)
7.15.5 LG Life Sciences Key News & Latest Developments
7.16 Serum Institute
7.16.1 Serum Institute Company Summary
7.16.2 Serum Institute Business Overview
7.16.3 Serum Institute Human Vaccination Major Product Offerings
7.16.4 Serum Institute Human Vaccination Sales and Revenue in Global (2018-2023)
7.16.5 Serum Institute Key News & Latest Developments
7.17 Pfizer
7.17.1 Pfizer Company Summary
7.17.2 Pfizer Business Overview
7.17.3 Pfizer Human Vaccination Major Product Offerings
7.17.4 Pfizer Human Vaccination Sales and Revenue in Global (2018-2023)
7.17.5 Pfizer Key News & Latest Developments
8 Global Human Vaccination Production Capacity, Analysis
8.1 Global Human Vaccination Production Capacity, 2018-2029
8.2 Human Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Vaccination Supply Chain Analysis
10.1 Human Vaccination Industry Value Chain
10.2 Human Vaccination Upstream Market
10.3 Human Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Human Vaccination in Global Market
Table 2. Top Human Vaccination Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Vaccination Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Vaccination Revenue Share by Companies, 2018-2023
Table 5. Global Human Vaccination Sales by Companies, (Units), 2018-2023
Table 6. Global Human Vaccination Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Vaccination Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Human Vaccination Product Type
Table 9. List of Global Tier 1 Human Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Vaccination Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Vaccination Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Vaccination Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Vaccination Sales (Units), 2018-2023
Table 15. By Type - Global Human Vaccination Sales (Units), 2024-2029
Table 16. By Application – Global Human Vaccination Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Vaccination Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Vaccination Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Vaccination Sales (Units), 2018-2023
Table 20. By Application - Global Human Vaccination Sales (Units), 2024-2029
Table 21. By Region – Global Human Vaccination Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Vaccination Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Vaccination Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Vaccination Sales (Units), 2018-2023
Table 25. By Region - Global Human Vaccination Sales (Units), 2024-2029
Table 26. By Country - North America Human Vaccination Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Vaccination Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Vaccination Sales, (Units), 2018-2023
Table 29. By Country - North America Human Vaccination Sales, (Units), 2024-2029
Table 30. By Country - Europe Human Vaccination Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Vaccination Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Vaccination Sales, (Units), 2018-2023
Table 33. By Country - Europe Human Vaccination Sales, (Units), 2024-2029
Table 34. By Region - Asia Human Vaccination Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Vaccination Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Vaccination Sales, (Units), 2018-2023
Table 37. By Region - Asia Human Vaccination Sales, (Units), 2024-2029
Table 38. By Country - South America Human Vaccination Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Vaccination Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Vaccination Sales, (Units), 2018-2023
Table 41. By Country - South America Human Vaccination Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Human Vaccination Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Vaccination Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Vaccination Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Vaccination Sales, (Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK Human Vaccination Product Offerings
Table 48. GSK Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Human Vaccination Product Offerings
Table 52. Merck Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Human Vaccination Product Offerings
Table 56. Sanofi Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Sinovac Company Summary
Table 59. Sinovac Human Vaccination Product Offerings
Table 60. Sinovac Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sinovac Key News & Latest Developments
Table 62. Zhejiang Pukang Company Summary
Table 63. Zhejiang Pukang Human Vaccination Product Offerings
Table 64. Zhejiang Pukang Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Zhejiang Pukang Key News & Latest Developments
Table 66. Changchun Institute of Biological Company Summary
Table 67. Changchun Institute of Biological Human Vaccination Product Offerings
Table 68. Changchun Institute of Biological Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Changchun Institute of Biological Key News & Latest Developments
Table 70. KM Biologics Company Summary
Table 71. KM Biologics Human Vaccination Product Offerings
Table 72. KM Biologics Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. KM Biologics Key News & Latest Developments
Table 74. IMBCAMS Company Summary
Table 75. IMBCAMS Human Vaccination Product Offerings
Table 76. IMBCAMS Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. IMBCAMS Key News & Latest Developments
Table 78. Convac Company Summary
Table 79. Convac Human Vaccination Product Offerings
Table 80. Convac Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Convac Key News & Latest Developments
Table 82. NCPC Company Summary
Table 83. NCPC Human Vaccination Product Offerings
Table 84. NCPC Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. NCPC Key News & Latest Developments
Table 86. Bio Kangtai Company Summary
Table 87. Bio Kangtai Human Vaccination Product Offerings
Table 88. Bio Kangtai Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Bio Kangtai Key News & Latest Developments
Table 90. Dynavax Company Summary
Table 91. Dynavax Human Vaccination Product Offerings
Table 92. Dynavax Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Dynavax Key News & Latest Developments
Table 94. Hissen Company Summary
Table 95. Hissen Human Vaccination Product Offerings
Table 96. Hissen Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Hissen Key News & Latest Developments
Table 98. KM Biologics Company Summary
Table 99. KM Biologics Human Vaccination Product Offerings
Table 100. KM Biologics Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. KM Biologics Key News & Latest Developments
Table 102. LG Life Sciences Company Summary
Table 103. LG Life Sciences Human Vaccination Product Offerings
Table 104. LG Life Sciences Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. LG Life Sciences Key News & Latest Developments
Table 106. Serum Institute Company Summary
Table 107. Serum Institute Human Vaccination Product Offerings
Table 108. Serum Institute Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Serum Institute Key News & Latest Developments
Table 110. Pfizer Company Summary
Table 111. Pfizer Human Vaccination Product Offerings
Table 112. Pfizer Human Vaccination Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Pfizer Key News & Latest Developments
Table 114. Human Vaccination Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 115. Global Human Vaccination Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Human Vaccination Production by Region, 2018-2023 (Units)
Table 117. Global Human Vaccination Production by Region, 2024-2029 (Units)
Table 118. Human Vaccination Market Opportunities & Trends in Global Market
Table 119. Human Vaccination Market Drivers in Global Market
Table 120. Human Vaccination Market Restraints in Global Market
Table 121. Human Vaccination Raw Materials
Table 122. Human Vaccination Raw Materials Suppliers in Global Market
Table 123. Typical Human Vaccination Downstream
Table 124. Human Vaccination Downstream Clients in Global Market
Table 125. Human Vaccination Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Vaccination Segment by Type in 2022
Figure 2. Human Vaccination Segment by Application in 2022
Figure 3. Global Human Vaccination Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Vaccination Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Vaccination Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Vaccination Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Vaccination Revenue in 2022
Figure 9. By Type - Global Human Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Vaccination Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Vaccination Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Vaccination Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Human Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Vaccination Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Vaccination Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Vaccination Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Human Vaccination Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Vaccination Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Vaccination Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Vaccination Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Vaccination Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Vaccination Sales Market Share, 2018-2029
Figure 23. US Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Vaccination Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Vaccination Sales Market Share, 2018-2029
Figure 28. Germany Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Vaccination Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Vaccination Sales Market Share, 2018-2029
Figure 37. China Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Vaccination Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Vaccination Sales Market Share, 2018-2029
Figure 44. Brazil Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Vaccination Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Vaccination Sales Market Share, 2018-2029
Figure 48. Turkey Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Vaccination Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Vaccination Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Human Vaccination by Region, 2022 VS 2029
Figure 54. Human Vaccination Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のヒト用ワクチン接種市場予測2023-2029：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他] (コード：MMG23LY8782)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒト用ワクチン接種市場予測2023-2029：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の日本脳炎ウイルスワクチン市場予測2023-2029：不活化ワクチン、弱毒化生ワクチン
  • 世界の結合型ワクチン市場2022-2029：種類別（一価結合型ワクチン、多価結合型ワクチン）、疾患別（肺炎球菌、インフルエンザ、ジフテリア・破傷風・百日咳（DTP）、髄膜炎菌感染症、その他）、病原体種類別（細菌結合型ワクチン、ウィルス結合型ワクチン、混合（ウイルス・細菌）結合型ワクチン）、エンドユーザー別（小児科、成人）、地域別
  • 世界の農業用動物ワクチン市場2022年：生ワクチン、不活化ワクチン、その他
  • VLPベースワクチンのグローバル市場2023年：弱毒生ワクチン、不活化ワクチン、組換えワクチン、トキソイドワクチン
  • 世界の家禽＆家畜ワクチン市場2022年：生ワクチン、不活化ワクチン

    • ◆H&Iグローバルリサーチのお客様（例）◆